Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Intravenous and Intranasal Naloxone in Healthy Volunteers
NCT06306391Phase 1Completed
- Sponsor
- Parc de Salut Mar
- Start
- Mar 2024
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of naloxone in opioid overdose (2 arms), sponsored by Parc de Salut Mar. Primary endpoints: Heart Rate at 6 hours, Systolic Blood Pressure at 6 hours and 4 more. Started Mar 2024; status: completed.
02
Drugs
naloxone
03
Conditions
opioid overdose
Beyond the preview
Go deeper on NCT06306391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06306391.